ES Newlands

Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy

D.B. Smith, ES Newlands, Gordon Rustin et al. · The Lancet · 1991 · 211 citations

Medicine, Oncology, Pharmacology +8

Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours

Sophie D. Fosså, Sally Stenning, A. Gerl et al. · British Journal of Cancer · 1999 · 148 citations · Full text

Medicine, Oncology, Surgery +17

3-aminobenzamide and/or O6-benzylguanine evaluated as an adjuvant to temozolomide or BCNU treatment in cell lines of variable mismatch repair status and O6-alkylguanine-DNA alkyltransferase activity

JK Porteous, ES Newlands · British Journal of Cancer · 1996 · 122 citations · Full text

Medicine, Cancer Biology, Oncology +17

Secondary tumours following etoposide containing therapy for germ cell cancer

Chris Boshoff, Richard H. J. Beǵent, R.T.D. Oliver et al. · Annals of Oncology · 1995 · 111 citations · Full text

Medicine, Oncology, Pharmacology +8

Pharmaco-kinetics of melphalan following oral or intravenous administration in patients with malignant disease

Martin H.N. Tattersall, Michael Jarman, ES Newlands et al. · European Journal of Cancer (1965) · 1978 · 99 citations

Medicine, Pharmacokinetics, Pharmacology +14